Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance - Wikidata - awgldk - TriplyDB

Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance

Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance

http://www.wikidata.org/entity/Q28305870

about

Immunotherapy for lung cancer: advances and prospects Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer.Cancer-testis (CT) antigen expression in medulloblastoma.Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications.The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer.Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma.Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses.Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas ligand pathway.Rates of MAGE-A3 and PRAME expressing tumors in FFPE tissue specimens from bladder cancer patients: potential targets for antigen-specific cancer immunotherapeutics.DNA vaccines, electroporation and their applications in cancer treatment EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays.Myeloid-derived suppressor cells enhance the expression of melanoma-associated antigen A4 in a Lewis lung cancer murine model MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer.Molecular profiling of tumor-specific TH1 cells activated in vivo.Identification of novel helper epitopes of MAGE-A4 tumour antigen: useful tool for the propagation of Th1 cells.Subtypes of cytotoxic lymphocytes and natural killer cells infiltrating cancer nests correlate with prognosis in patients with vulvar squamous cell carcinoma.The biology of cancer testis antigens: putative function, regulation and therapeutic potential Rationale for targeting the immune system through checkpoint molecule blockade in the treatment of non-small-cell lung cancer.Challenges and opportunities for cancer vaccines in the current NSCLC clinical scenario.Unmet needs in squamous cell carcinoma of the lung: potential role for immunotherapy.Cancer testis antigen and immunotherapy.Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non-small cell lung cancer.Adoptive immunotherapy using T lymphocytes redirected to glypican-3 for the treatment of lung squamous cell carcinoma A model for cancer-suppressive inflammation Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis.Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis.Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis.

P2860

Q26750617-2093DA51-B95F-44B5-98D0-62158B26E960 Q26782583-69F2C8C3-CFDF-4A66-B088-DAE84F1A4F64 Q33599094-47CDA62C-5365-4202-8DAB-9CB2E30385D1 Q34111864-399F5276-91AD-416B-B398-BADA1E5CABB1 Q34753747-351CB778-C42E-4D69-89C6-936C754C6B87 Q34917875-4E0583B6-C8AF-4C7D-9FF3-82A952396E59 Q35011313-AC942230-3F1F-4A88-99CF-1A0DA54C373A Q35586619-36189DC8-FA73-49BD-B8B6-84C602A3D554 Q35589288-04CF8C71-E594-446F-B8FE-6590A4D299FA Q36095397-9CD96A49-ADC6-455B-ACAC-B7885E487FF7 Q36256459-4A12890F-D930-48CF-BC0C-1B4195037EDA Q36285345-0B7DE4C2-36D2-474B-BEC3-38471A5BE2B6 Q36503123-76D4E34F-D62D-4953-AE05-301B0864CD5D Q36785925-32F01518-EAB2-47C6-918D-8396FF43D8F8 Q36887852-B51CB4E0-0704-4294-B1FC-AFCDE70AC22F Q37160648-464F54D9-DF35-4798-86ED-09116A8D85D2 Q37592023-AB788F2D-DBD8-4E3A-BC29-67AE48A5A683 Q37849976-8B5D5DFB-275A-47BF-BE2E-16C4331D2A43 Q38080047-4AA81DD7-E2A3-4B27-83A8-323E3DC3516F Q38143201-49946A34-E458-49D3-88DF-3790C9B77236 Q38205723-5C5EFCBB-EF59-4DE2-B6A5-2DBB393AD806 Q38912232-70D196E4-95BF-465E-B504-833EC1E0C3D4 Q38938285-FEF6F6DE-6494-4188-924D-60CD9467B910 Q39924228-23DDF62B-97A7-40A4-9B15-443CAF51C85D Q41275639-13668E1C-EE08-4DC4-8D4C-B88092CD1ABB Q41294153-941509B5-881A-40FE-B0B1-4ADCBF9B5D68 Q55136811-D1946AA8-6569-4207-B440-2B3AB13113E4 Q55440274-1140EDD7-E675-4AD7-9028-6311DE0D6DA8

P2860

Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance

http://www.wikidata.org/entity/Q28305870

description

2006 nî lūn-bûn

@nan

2006 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Expression of the MAGE-A4 and ...... their prognostic significance

@ast

Expression of the MAGE-A4 and ...... their prognostic significance

@en

Expression of the MAGE-A4 and ...... their prognostic significance

@nl

type

label

Expression of the MAGE-A4 and ...... their prognostic significance

@ast

Expression of the MAGE-A4 and ...... their prognostic significance

@en

Expression of the MAGE-A4 and ...... their prognostic significance

@nl

prefLabel

Expression of the MAGE-A4 and ...... their prognostic significance

@ast

Expression of the MAGE-A4 and ...... their prognostic significance

@en

Expression of the MAGE-A4 and ...... their prognostic significance

@nl

P1433

Q28305870-EAFF35B4-9ED6-4A71-A594-BF3BAFD8C56E

P1476

Q28305870-6080A308-4425-4BB3-9D5C-84B04D61C01C

P2093

Q28305870-023F2D9B-F717-4809-B78E-603D4B6D0A97

Q28305870-0B98DCCA-BCF5-40CC-A02C-5B1AD679E8AF

Q28305870-35EF173C-030B-4DEA-9F92-97B123A7160E

Q28305870-429AE784-C355-48A0-8364-89C884539149

Q28305870-4815BE95-ED64-4CF3-9413-3A43075FA6C9

Q28305870-653AA40A-7894-4D42-9693-B0CD03EB77B4

Q28305870-81F1FF11-4FA6-4072-8C0A-E0C85EAE0E12

Q28305870-91306029-DB65-4088-A056-E0E6312D915A

Q28305870-98BA48A8-43A4-4BA5-AD5C-9B97EB1CF708

Q28305870-D8744087-2EFC-4C47-BC15-3045DC58D30D

P304

Q28305870-091C3B9F-E881-41F2-8F75-7B34EC5F0677

P31

Q28305870-9B344A73-632E-4B3A-A4DA-57ADD7A08822

P407

Q28305870-A39FF5B5-8CC5-4FCB-B9C4-9A248E482895

P433

Q28305870-C256DA23-3DDA-4C7E-9C72-9D774E94D465

P478

Q28305870-DDE1457E-3506-4E41-9E58-1059AFB3D93B

P577

Q28305870-2C494577-CDDE-45AC-B54D-A019F9E3A09E

P698

Q28305870-C58BFFD3-7B90-4FDF-A517-0BACF9B046D5

P1433

International Journal of Oncology

P1476

Expression of the MAGE-A4 and ...... their prognostic significance

@en

P2093

Daiko Wakita

http://www.w3.org/2001/XMLSchema#string

Daisuke Noguchi

http://www.w3.org/2001/XMLSchema#string

Hiroaki Ikeda

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Abe

http://www.w3.org/2001/XMLSchema#string

Masaki Miyamoto

http://www.w3.org/2001/XMLSchema#string

Masayoshi Sato

http://www.w3.org/2001/XMLSchema#string

Naofumi Yoshida

http://www.w3.org/2001/XMLSchema#string

Satoshi Kondo

http://www.w3.org/2001/XMLSchema#string

Takashi Nishimura

http://www.w3.org/2001/XMLSchema#string

Takayuki Ohkuri

http://www.w3.org/2001/XMLSchema#string

P304

1089-98

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16596224

http://www.w3.org/2001/XMLSchema#string